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Objectives:  To provide a critical reflection of COVID-19 in the context of oncology nursing and 
provide recommendations for caring for people affected by cancer during this pandemic. 
Data sources: Electronic databases including CINAHL, MEDLINE, PsychINFO, Scopus, professional 
websites, and grey literature were searched using Google scholar. 
Conclusion:  Nurses are key stakeholders in developing and implementing policies regarding 
standards of care during COVID-19 pandemic.  This pandemic poses several challenges for oncology 
services.   Oncology nurses are providing a pivotal role in the care and management of the novel 
COVID-19 in the year landmarked as the International Year of the Nurse. 
Implications for practice:  It is too early to tell what shape this pandemic will take and its impact on 
oncology care.  However, several important clinical considerations have been discussed to inform 
oncology nursing care and practice.  
 












Since late December 2019, a novel coronavirus (COVID-19)  has resulted in an ongoing pandemic of 
viral pneumonia, which started in Wuhan, China [1, 2].  As of 13th April 2020, COVID-19 has affected 
213 countries worldwide [3].  In general, COVID-19 is an acute illness but it can be deadly, with an 
average case fatality of 2%  [4].  COVID-19 causes severe respiratory illness associated with an 
Intensive Care Unit (ICU) admission, mechanical ventilation and high mortality [5].  The presenting 
symptoms of COVID-19 include: fever, chills, cough, fatigue and shortness of breath [1, 4, 5].  There 
is recent anecdotal evidence that anosmia with resultant dysgeusia are frequently reported 
symptoms with COVID-19. 
In this global critical care crisis and unparalleled health emergency, nurses are the largest healthcare 
professional group providing frontline care. Nurses’ pivotal role in the care and management of the 
novel COVID-19 comes in the year landmarked as the International Year of the Nurse [6]. This global 
crisis is uncharted territory and the first of its kind for most nurses’ living memory bringing along 
new challenges already recognised by international nursing boards [7-10].  At the time of writing this 
critical reflection, global incidence passes 1, 699 595 with more than 106, 138 fatalities see Figure 1.   
COVID-19 and cancer 
Early COVID-19 outcome data has suggested a fatality rate of 5.6% among those affected by cancer 
[11].  A further study identified that people affected by cancer had a 3.5 times higher risk of severe 
COVID-19 disease than other patient groups [12].  Around the world vulnerable groups at risk of 
COVID-19 are people with specific cancers including those: undergoing active chemotherapy and 
radical radiotherapy for lung cancer; blood or bone marrow cancers such as, leukaemia or multiple 
myeloma (at any stage of disease); those receiving immunotherapy; antibody treatments for cancer; 
targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors;  
individuals who have received a bone marrow or stem cell transplant in the last 6 months; or those 
taking immunosuppression drugs [13].  People affected by cancer could be at elevated risk of severe 
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COVID-19 disease and may experience disrupted and delayed delivery of cancer therapies because 
of social distancing measures, quarantines, and general disruption in routine cancer service during 
this pandemic.    
Therefore, this article aims to provide a critical reflection of COVID-19 in the context of caring for 
people affected by cancer. Given that new, emerging evidence will rapidly develop over time in this 
clinical context, the authors would recommend nurses and clinicians to access official websites for 
regular updates as they emerge over the course of this pandemic, such as those provided in Table 1. 
Historical Nursing Perspectives on Global Pandemics 
In the Preface to their book, Nurses on the Front Line: When Disaster Strikes, Wall and Keeling note: 
“What nurses did in the past can inform disaster preparations for today … providing historical 
evidence to inform disaster policies for the future” [14, p xi]. As co-editors and contributors, Wall 
and Keeling asked authors to analyse nurses’ roles as components of community responses to 
disasters that occurred in regions in the United States, Canada, Turkey and Haiti – communicable 
diseases, earthquakes, hurricanes, accidents, and intentional and unintentional human errors. 
“Nurses”, they contend, are in positions “to participate in all aspects of the disaster response, 
including evacuation, triage, physical and psychological care at the scene and afterward, case 
finding, screening measures, vaccinations, and disease surveillance” [14, p xii]. 
The 1918 Influenza epidemic in the United States. When viewed over the past century, similarities 
exist between the 1918 Influenza pandemic and the 2019-2020 pandemic attributed to another 
Coronavindae -  SARS-CoV-2 - one of seven such microbes known to affect humans, causing the 
clinical entity referred to as COVID-19 [15]. The similarities justify exploring challenges encountered 
by nurses “on the front lines” and challenges arising during the 1918 Influenza Pandemic. Both 
entities are rapidly transmitted through person-to-person and close contact; Both are marked by 
rapid expansion and spread; Both are characterized by rapid increases of cluster cases. Clinical signs 
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and symptoms of COVID-19 are often confused with influenza: fever, cough, sore throat, muscle 
soreness and dyspnea. And finally, both disease entities have high mortality rates.  
The origins of the 1918 influenza pandemic are said to be “inextricably associated with the soldiers 
who fought during the First World War” [16, p 190].  Between 1918 and 1919, the last two years of 
this war, a third of the global population is estimated to have been infected with influenza [17]. Over 
675,000 influenza-related deaths in the United States during this time frame are attributed to this 
virus. Still evolving estimates indicate that the influenza type A virus responsible for the 1918 
Influenza Pandemic (also sometimes referred to as the “Spanish Influenza” or the “Spanish Lady”) 
killed between 21.5 to 50 million people between 1918 and 1920. Even then, the real death toll may 
still be understated by as much as 100 percent [17, 18]. According to Taubenberger and Morens, “… 
all influenza A pandemics since that time, and indeed almost all cases of Influenza A worldwide have 
been caused by descendants of the 1918 virus” [17, p 15], leading them to refer to the 1918 
Influenza as “The Mother of All Pandemics” [17, p 16].  
Keen-Payne [19]), Deming [20], and Keeling [21] provide vivid narrative descriptions of nurses’ 
efforts and contributions during the 1918 influenza pandemic. Keen-Payne [19] suggests that effects 
of this pandemic  are hidden by actions and states of organized medicine and nursing at the time, 
the status of health, science, healthcare, and public health in the United States, the context of World 
War I, and its immediate global aftermath.  
Keen-Payne’s historical study reveals [19] contagion control in various urban areas, though not 
standardized, was addressed in several ways. In Chicago, Illinois, persons who sneezed or spit openly 
were threatened with arrests and fines; churches – ventilated by open windows during services - 
were not closed but ill parishioners were asked to stay home. Theatres, banquets, lectures, 
restaurants and movies were closed.  Newark, New Jersey officials allowed liquor stores to stay open 
for sales only – a move protested by local church leaders. Newark hospitals are described as 
“overwhelmed with civilians and soldiers from nearby military bases” [19, p 150]. In San Diego, 
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California all public facilities were closed. Many cities required face masks – fashioned with layers of 
square gauze tied at the top of the head and the back of the neck - to be worn in public; Compliance 
varied. Social systems were disrupted including telephone service, public transportation (train and 
taxi operators became ill), and nurses, firefighters, teachers, and priests were sick and absent from 
work.  Lillian Wald, founder of public health nursing in New York wrote to a friend explaining that 
40,000 nurses were needed to provide necessary services to the city’s poor [19, p 150].  
As a student nurse, Dorothy Deming’s [20] reflection of her 1918 Influenza pandemic experience 
noted how swiftly the “attack” occurred: “No one anticipated the suddenness of the attack. … 
Almost overnight the hospital was inundated by flu victims [20, p 1308]. Her hospital (with capacity 
of 250-beds) admitted 850 patients with flu or flu-like pneumonia during six weeks.” She notes a 
shortage of nurses during this time – with more than 50 nurses in military service overseas. Deming 
specifically observed the emotional impact of this work:  
“[My classmate and I] were fairly well prepared for this ordeal: prepared, that is, for all but the 
emotional impact of the situation…. Until the epidemic, death had seemed kindly, coming to the 
very old, the incurably suffering, or striking suddenly with the knowledge of its victim. Now we saw 
death clutch cruelly and ruthlessly at vigorous, well-muscled young women in the prime of life” [20, 
p 1309].   
Seeing the difficulty of having so little to offer patients and families, Deming says: 
“In 1918, we had no miracle drugs, no antibiotics, no oxygen or suction equipment at every bedside. 
We knew of efforts to develop a vaccine … but never saw its results in our wards. … Over and over 
again we heard the doctors say, after writing a long list of orders which we came to know almost by 
heart, ‘Now everything depends on good nursing.’ We tried our best” [20, p1309].  
Nevertheless, Deming concludes: “Those were dedicated weeks, as truly under fire as though we 
were with our brothers in the Argonne. Life was just one long emergency. … For me, nursing came 
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alive during that test” [20, p 1309]. D’Antonio and Whelan [22] convey nurses’ critical roles in 
preventing greater spread of influenza and reducing the severity of the pandemic they view as “the 
most devastating epidemic in history” (p 70). Nurses taught “individuals, families and communities 
about respiratory hygiene, handwashing, disinfection of household utensils, and the critical 
importance of wearing gauze masks” (p 70) … while also providing care for people already stricken 
with the disease. Special acknowledgement is offered to student nurses, who “provided almost all of 
the nursing care delivered in U.S. hospitals” – remaining at patients’ bedsides throughout the 
pandemic during; hundreds of them died” (p 70).  
In a review of disaster nursing literature, Wall and Keeling [14] identify seven shared themes 
regardless of time, place, and circumstance:   
“1) improvised activities at local and national scenes; 2) cooperation and collaboration among 
previously established professional and social networks; 3) leadership and courage; 4) spontaneous 
community support; 5) restoration of order out of chaos; 6) creation of healing narratives; and 7) the 
crossing of cultural, geographic, and professional boundaries in response to the crisis “ (p xii).   
Public Health Approach to the Epidemiology of Infectious and Contagious Diseases 
In 2019, the Johns Hopkins Center for Health Safety released its report, Preparedness for a High-
Impact Respiratory Pathogen Pandemic” [23] after examining the state of global preparedness for 
pandemics caused by pathogens with potential for widespread transmission and high mortality. The 
assessments undertaken identified significant national and international readiness gaps around 
detection and containment, challenges relating to tools, personnel, surveillance systems, and global 
governance and response [23].   
The Public Health approach see Figure 2, used now is not much different than that used 1918. 
Application of epidemiologic sciences see Figure 3, are useful in identifying distribution and 
determinants of health problems and suggestion of potential mitigation strategies (Centers for 
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Disease Control,[24]. Efforts to solve health problems generally follow a four-step scientific approach 
involving data collection, assessment, hypothesis testing, and action. In the public health approach, 
data are collected, and an initial assessment (or hypothesis) is conducted. The hypothesis is tested, 
and resulting information is used to devise interventions.  As in all sciences, epidemiology applies 
key terms – noted in Table 2 [24]. 
Of COVID-19, initially identified as a “novel coronavirus”, Medical historian Howard Markel, known 
for his studies of the 1918 flu epidemic says: “The key word about this coronavirus is ‘novel’ – we 
don’t have any experience with COVID-19…[and] we won’t know it’s over until long after it’s over” 
[25, p 3].   Gaps remain in our understanding of its molecular structure, the infectious nature of this 
particular coronavirus, identifying characteristics of COVID-19 diagnoses, modes and rapidity of 
transmission, definition of contacts, and the public health management based on observations of 
similar coronaviruses.  
New and important data describing the biology, epidemiology, and clinical spectrum of COVID-19 
appears almost daily: del Rio and Malani [26] note more than 400 articles listed in PubMed since the 
outbreak was first reported in late 2019 – challenging even the most attentive readers to stay 
abreast of the recent findings and clinical guidance. Critical pieces of information remain missing for 
traditional epidemiologic sciences and practices to be fully applied to effective screening and testing 
[27].  
Soon after the Wuhan outbreak was reported, field investigations for suspected and confirmed cases 
and collection of case respiratory specimens were conducted, initially arriving at the working case 
definition of “Novel Coronavirus-Infected Pneumonia” (NCIP) based on previous coronavirus case 
definitions. Suspected case epidemiologic criteria were devised. Accurate and adequate testing 
capabilities, essential to confronting the outbreak and Identification of people with infection despite 
minimal symptoms remain an unmet need [26].  Widespread testing is not implemented in many, if 
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not most countries, severely limiting our understanding of the basic biology of this newly discovered 
virus, and development of effective countermeasures [27].   
Contact Identification and Tracing 
Until an anti-COVID-19 vaccine is developed and deployed, the most effective means of interrupting 
transmission, preventing new cases and complications is the public health process contact tracing 
[28]. Individuals who have been in close contact – within six feet of an infected person for a 
prolonged period of time - are at risk of becoming infected themselves, and further infecting others. 
Close monitoring of contacts exposed to an infected person facilitates early diagnosis and treatment, 
preventing further viral transmission. This 3-step monitoring process is referred to as “contact 
tracing” (WHO [29]): 1) Contact identification – after a person has a confirmed infection, 
identification of contacts involves interviews to identify the person’s activities, and roles of people 
around them since the onset of illness. Contacts include anyone who has been in contact with the 
infected person – family members, work colleagues, friends, and health care providers. 2) Contact 
listing – Any persons known to have contact with the infected person are listed as “contacts”, and 
efforts are made to identify each contact, inform them of their at risk status, actions to follow, 
information about accessing early care, and disease prevention and mitigation strategies – 
quarantine or isolation is required for high risk contacts. 3) Contact follow-up – is a painstaking, 
resource intensive, and expensive process, though technologic advances can diminish the intensity 
of such tasks. Regular follow-up of close contacts generally consists of daily telephone calls, text 
messaging, and/or in-person inquiries about fever and other symptoms for 14 days after the last 
known exposure to a person with confirmed COVID-19. If and when close contacts develop new or 
worsening symptoms, they are referred for diagnostic testing and appropriate treatment.   
Contact tracing is dependent on preconditions including eliminating barriers to testing. When testing 
is not fully implemented, public health strategies cannot follow lines of transmission. Another 
precondition reflects the penetration of the disease in a given community: the disease burden must 
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be low enough to make it practical to investigate potentially infected persons, symptomatic or not. 
Contact tracing is most useful in containing flareups and preventing exponential growth of new cases 
[28].  
COVID-19 is a new disease and there is limited information regarding risk factors for severe disease. 
Based on currently available information and clinical expertise, older adults and people of any age 
who have serious underlying medical conditions [30]might be at higher risk for severe illness from 
COVID-19. Emerging evidence supports necessary acknowledgement of populations at higher risk for 
COVID-19, including adults over age 65, individuals with underlying conditions including obesity, 
diabetes, hypertension, and those who are immunocompromised by diseases – including cancer – 
and treatments that impair the immune system [31]. Although studies exploring effects of COVID-19 
on cancer care are so far, very limited,  it is surmised that people with cancer and cancer survivors 
may well be at higher risk for developing complications relating to COVID-19 – including need for 
intensive care, mechanical ventilation and death. A Lancet Oncology editorial [32] notes pressures 
put upon health-care systems struggling to near breaking points as resources are diverted to 
respond to the COVID-19 crisis. Less considered as the COVID-19 crisis continues throughout the 
world, may be cancellation of conferences, jeopardy and prioritising of research trials and projects, 
absence of practical laboratory work and field studies, and other consequences for research, 
education and collaboration. The world’s largest annual oncology nursing conference, that of The 
Oncology Nursing Society, scheduled for April 30-May 3, 2020, was cancelled.   
Clinical Presentation COVID-19 
Published reports have identified that the clinical presentation of COVID-19 is most frequently 
associated with fever (90%-98%), non-productive cough and sore throat (59%-76%) and lethargy 
(38%-70%) [33-35]. Less frequent reported symptoms include abdominal pain, dizziness, headache, 
diarrhea, nausea and vomiting [34].  Shortness of breath is another presenting feature with a median 
time of development reported at five to eight days (range of three to nine) from initial onset [34].   
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Patients have also been found to have radiological evidence of pneumonia [5]. In severe COVID-19 
cases patients will experience organ dysfunction: shock, acute respiratory distress syndrome (ARDS), 
acute cardiac arrest, acute kidney failure and death can occur in severe cases [5].  Moreover, 
emergent evidence has identified that a subgroup of patients with severe COVID-19 experience 
cytokine storm syndrome [36].  It is recommended that all patients with severe COVID-19 should be 
screened for hyperinflammation (ferritin, platelet count and erythrocyte sedimentation rate) as 
immunosuppression with corticosteroids can decrease mortality for a subgroup of patients [36].  
Case reports have identified human-to-human transmission [37, 38].  At present, there are no 
effective vaccines or therapies to treat COVID-19.  Diagnosis can be made from specific reverse 
transcription polymerase chain reaction (RT-qPCR) of  nasopharyngeal or oropharyngeal swabs, and 
lower respiratory tract samples [34].   
Oncology Nursing Considerations to COVID-19 
Globally, healthcare systems and policy responses to COVID-19 are evolving rapidly.  Of the 
estimated 43.5 million healthcare workers in the world, it is estimated that 20.7 million of those are 
nurses [39].  Therefore, nurses are at the forefront of this pandemic and are taking a proactive 
approach with multidisciplinary teams to participate in the pandemic planning within their health 
organisations. It is critical that nurses regularly review and follow institutional, specialist college, 
state level and government recommendations. Measures should be subject to an ongoing review 
that will reflect organisational, local, state-wide and national policies (including, criteria for COVID-
19 testing, self-isolation, social distancing, quarantine and personal protective equipment [PPE]).  
Service Delivery Impact 
Day -by -day there is a new release of information and new wave of regulations that impact the 
oncology service globally.  The rapid spread of COVID-19 has the potential to overwhelm primary 
and acute services as experienced in China [11] and Italy  [21].  The challenge to deliver oncology 
services is further compounded by COVID-19 infection spread to nursing and medical personnel, 
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school closures, all of which impact staffing levels.  Moreover, to create new local COVID-19 services 
means that there is an on-going re-shuffling and re-allocating of resource (human and budget) which 
puts additional strain on existing services that were already at full capacity.  Figures from China’s 
National Health Commission demonstrated that more than 3300 healthcare workers were infected, 
and 22 had died related to COVID-19  [40].  As the pandemic accelerates providing PPE to deliver  
safe oncology services is a key concern worldwide [12].  If acute care services are at maximum 
capacity, institutions may provide alternative provisions for the care of people affected by cancer.  
Therefore, oncology nurses will need to be flexible to facilitate the safe delivery of alternative 
models of care.  Alternative and adaptive models of care could increase the use of community care 
or private facilities.   
Following an analysis of nationwide data in China, a number of major strategies were put forward in 
the clinical management of cancer during this COVID-19 crisis [12].  First, that of intentional 
postponing of adjuvant chemotherapy or elective surgery for people with low risk cancers.  Second, 
should surgery suites and personnel be seconded elsewhere or are unavailable, neoadjuvant 
chemotherapy could be considered for timely delivery of oncologic manoeuvres for some 
malignancies. Hypofractionated radiotherapy protocols should be prescribed whenever possible 
[41], including single fraction treatments for uncomplicated bone metastases [42].  Third, protective 
approaches such as PPE and personal space modifications should be considered, see Table 3. During 
chemotherapy administration, treatment beds or chairs should be placed with adequate space (1.5 
meters) to prevent close contact as much as possible. Limiting or eliminating family attendance, 
while stressful, may be necessary in limited chemotherapy suite spaces. In such cases, portable 
technology such as smart phones or iPads could be loaned during the treatment session for patient 
and family support and subsequently disinfected between patient usage.  Finally, more intensive 
surveillance during and in the recovery period should be considered when patients with cancer are 
infected with COVID-19, especially older patients and those with multiple co-morbidities [12].  
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People affected by cancer with family members or those in close contact who are infected, or 
suspected with COVID-19, should isolate from these contacts.  Patients in such circumstances should 
be advised to inform their cancer care centre of any quarantine requirements.  It is important that 
current health department recommendations regarding isolation and quarantine are followed. All 
cancer centres should display the symptoms of COVID-19 disease, criteria for when medical advice 
should be sought, and state the appropriate mode of presentation.  For example, services may use a 
telephone triage, dedicated COVID-19 community assessment clinics [43] while some countries have 
built new COVID-19 hospitals within a very short timeframe with isolation and testing facilities.  
 
Impact of COVID-19 on the Nursing Workforce 
When facing a large-scale public health event, such as COVID-19, the physical and psychological 
strain on healthcare professionals cannot be underestimated [44].  It has been documented that the 
main concerns from healthcare staff during the COVID-19 outbreak in China have included being 
afraid of bringing the virus to their home and families [45].  Staff  articulated a lack of support in  
how  to  manage patients  when  they  were  unwilling  to  be  quarantined  at  the hospital, or when 
patients did not cooperate with medical  measures  because  of  panic [45].  Finally, staff  articulated 
concerns about  the  shortage of PPE and feelings of incapability  when  faced  with  critically  ill  
patients [45] and difficult decision-making in the allocation continuous positive airway pressure 
(CPAP) and ventilators. 
Experiences of health professionals during the severe acute respiratory syndrome (SARS) outbreak 
indicate a sequel of depression, anxiety, fear, frustration [46] and post-traumatic stress [44].  
Research is currently underway looking into the mental impact of working in the frontline with 
people infected by COVID-19. Initial data from a large sample (n=1257) in China suggest similar 
patterns, with half of the sample of frontline staff experiencing depression and anxiety [47]. In fact, 
being a female nurse indicated a higher risk for depression, anxiety and psychological distress [47].  
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Caring for deteriorating patients across all ages increases emotional strain and physical exhaustion 
[48]. This experience can be exacerbated when caring for people with cancer; additional burden is 
placed on overworked nursing staff as the focus shifts to life-preservation leaving no space for 
reflection. Re-allocation of the workforce to manage the pandemic can also increase feelings of 
anxiety due to potential lack of familiarity the new role [30]. These factors can result in suppressing 
the natural process of grief and loss and in the long-term may lead to faster professional burnout 
[48].  
Anxiety and depression are two of the most commonly experienced effects of cancer and its 
treatment [49]; these can be heightened in the face of an additional life-threatening condition such 
as COVID-19. Frontline staff are also concerned on how best to identify and manage mental health 
problems of patients infected by COVID-19, but also keep supporting those with pre-existing mental 
health issues. In existing mental health inpatients, emotional detachment has been observed as a 
coping strategy [50].  At this stage, affected access to mental health services for managing 
depression, anxiety, and psychological distress has been reported as a contributing factor for 
increasing staff stress levels [48]. The World Health Organisation (WHO) [51] has released a set of 
recommendations focussing on ways to cope during the pandemic of COVID-19. 
Pandemic Nursing Workforce Planning Strategies 
As the number of COVID-19 cases continue to increase, the urgency to flattening the curve [52] has  
enforced stringent measures to reduce exposure of patients and healthcare workers. Globally, 
health care organisations have shifted in their approach to care provision including: the conversion 
of clinic visits to telehealth, postponement of routine surveillance appointments, cancelling of 
elective procedures are some strategies to mobilise the nursing workforce reallocation to respond to 
other duties needed during this crisis. Figure 4 illustrates the nursing workforce during the pandemic 
phase.  Table 4 provides an overview of nursing considerations when developing alternative care 
delivery models.  
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Health care systems are faced with the increasing pressures of meeting the demands of the 
pandemic while continuing to meet the needs of the oncology patient population.  Emergency 
preparedness plans provides guidelines for maintaining operations during surge capacity. 
Department leaders are responsible for identifying core staffing levels for business continuity. Staff 
unassigned to specific duties within clinical areas may be deployed to a central labour pool to 
assume various work assignments.  Figure 5 is a sample algorithm providing guidance ensuring core 
staff availability for speciality area prior to deployment of staff to a labour pool.   A comprehensive 
assessment of previous healthcare experience, competencies, technical skills and capabilities of 
healthcare workers is a prerequisite to identify educational and training needs during a pandemic. 
Health care organisations are expected to experience staff shortages and strategies to maintain 
business operations may include: 
1. Staff alternate work agreements. Telecommuting preserves the health of the cancer 
workforce by reducing the risk of exposure to COVID-19 in roles where permitted. With 
adequate technology, nursing triage, care coordination or navigation, patient education can 
be reallocated to those nurses with work restrictions/health concerns.   To reduce the 
frequency of oncology outpatient appointments nurses can provide telehealth wellness 
appointments. 
2. Consolidation of services and alternate plan for low staffing. Department leaders should 
identify a discipline specific staffing threshold that will require a change in standard work. 
The plan will identify duties or tasks that can be suspended, shifted to other another team 
member, or shifted to other department.  A consolidation plan should be considered to co-
locate like services. Expansion of staff work hours may be necessary. 
3. Emergency privileges. Temporary or emergency privileges of licensed independent 
practitioners can be granted to facilitate delivery of critical patient care.   
4. Hiring temporary staff. Providing access for external clinical and non-clinical workers to 
apply for temporary positions during the pandemic should be considered. A survey assessing 
16 
 
current role, availability, experience in a healthcare setting, any specialty clinical experience, 
and a brief skills inventory will inform appropriate placement. A dedicated team reviewing 
applications, conducting interviews 7-days a week with flexible hours, and making prompt 
offers to qualified individuals is crucial. 
5. Staff cross-training. Abbreviated orientation to deploy staff to other clinical areas will be 
important to rapidly activate the nursing labour pool. 
 
Supportive care  
Supportive care is defined as a person-centred approach to the provision of tailored services for 
those living with or affected by cancer to meet their physical, psychological, social, spiritual or 
informational needs during diagnosis, treatment, or follow-up phases including survivorship, 
palliation and bereavement [53].  People affected by cancer during this pandemic may have different 
areas of unmet supportive care needs than those already identified in existing systematic reviews 
[53-59].  There is now a greater need for patients to develop their confidence and capability in self-
management self-efficacy [60] to manage their physical and psychological wellbeing unsupervised 
for some patients in the community setting.  Nurses play a vital role in supporting self-management 
and education while providing alternative models of care during the pandemic.   
Many people affected by cancer, and their loved ones will be distressed and concerned about the 
real-life impact of COVID-19. It is likely that patients will have a range of unmet informational needs 
because COVID-19 disease recommendations are likely to change frequently.  Oncology nurses 






Social isolation/loneliness  
As countries are affected by COVID-19 many are implementing social distancing measures, 
quarantine, self-isolation and hospital visitor limitations, which undoubtedly will limit opportunities 
for family support and advocacy.  For patient with cancer at high risk of COVID-19 they are being 
advised to stay at home for a very long-time.  Moreover, patients in this high-risk group are being 
advised to stay away from others, including close family members who do not stay in the same 
household.  For example, in the United Kingdom (UK) patient with cancer care being told to self-
isolate up -to -six months [61].  To shield the high-risk groups worldwide and reduce the burden on 
acute care and ICU beds, countries are enforcing lockdowns, curfews, and social isolation to mitigate 
the spread of this disease.  Evidence has already underscored that people affected by cancer can 
experience loneliness [62, 63] prior to the COVID-19 pandemic.  Inevitability, behavioural changes in 
society  for people affected by cancer will impact the experience of boredom [64], sense of 
connection, social support (including access to emotional, informational, practical and financial) [65], 
loneliness and anger [64].  Moreover, a recent study has shown that people affected by cancer 
during this pandemic are at increased risk of depression [66].  We strongly advocate for services to 
recognise these impacts and seek to provide support and intervention using safe non-physical 
support and contact, such as video or digital technologies [67, 68] or nurse -led telephone services 
[69]. 
Palliative Care 
Palliative care services are also affected, facing one of the greatest challenges from the impact of the 
pandemic. Learning from previous experience on epidemics, the authors have identified issues 
relating to space and workforce, psycho-social challenges and issues related to the new profile of the 
patients that will require palliative care services [70]. To date, there is limited evidence on the role of 
palliative care on managing the COVID-19 pandemic when it should be one of the key components in 
the strategies. The limited capacity of services to deal with the volume of affected people and 
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families and protective isolation measures that aim to contain transmission can both result in limited 
or no visiting from family members impacting preparatory grief processes and the notion of having a 
good death. Charitable organisations currently offer a range of support services to the public 
affected by COVID-19 [70, 71]. 
COVID-19 Clinical Trials/Participation in Research 
Clinical trials in oncology are the most vital approach to improving the management and potential 
cures for multiple malignancies. Participation in phase 2 and 3 pharmaceutical trials allow thousands 
of patients to potentially access and benefit from novel therapeutics. Furthermore, the findings from 
basic cancer research has informed the development of interventional research in multiple other 
devastating chronic and acute diseases.  
Individual researchers must be aware of issues and guidance specific to their jurisdiction and 
research methodology. Drug, device and biological product trials may be immediately impacted. 
Facility closures, quarantines and travel restrictions are only a few of the potential restrictions to 
timely clinical trial conduct [32]. Clinical trials personnel and/or trial participants may become 
infected with COVID-19.  
Specific to clinical trial conduct, protocol modifications will be required [72, 73]. Unavoidable 
protocol deviations and violations will occur as a result of treatment administration or follow-up 
timing, availability of supportive medications, or multiple other issues specific to a study. Ultimately, 
safety of the participants and study personnel, maintaining compliance with good clinical practice 
[74] and minimizing risks to trial integrity remain the critical considerations of principal investigators. 
Alternative approaches to participation, for example, alternative methods for assessments and 
follow-up such as phone or video contact offer not only trial compliance but decreased exposures. 




Recognizing the many approaches in oncology research, investigators may benefit by considering 
alternative methodologies. Surveys, quality of life questionnaires and interviews (individual or online 
groups) may provide opportunities to explore the cancer experience and avoid viral exposures.  
Oncology Nursing Leadership during Crisis Management 
As a global profession facing a pandemic, leadership lessons can be learned from prior natural 
disasters, human-created crises, and pandemics to best support the care of patients and healthcare 
workers (HCW). Healthcare workers and first responders are often the first ones to arrive and care 
for those in need. Transformational leadership is critical during this time as well as a structured 
approach to best support the smallest to largest clinical operation. Transformational leaders are 
critical during this time of rapid change when policies and protocols are rapidly evolving, and 
ambiguity is a constant. Leaders may shift their style in response to the criticality of an event and 
what is deemed important versus urgent due to the respective timelines of acquiring, negotiating, 
and planning for critical items to care for patients as well as HCWs. 
Healthcare workers suffer during and after crises and psychological first aid is paramount during and 
after such events [75-77].  Addressing Maslow’s hierarchy of needs and ensuring HCWs safety 
(emotional, physical, and mental) is paramount while a new normal is evolving [78]. The oncology 
nurse leaders’ abilities are critical as they often manage the largest segment of the workforce and 
need to remain calm, collaborative, and think critically as the situation unfolds. Crisis management 
and communication plans are critical to organizations. Edmondson and colleagues outline the need 
for nurse leaders to understand the tenets of crisis communication, key behaviours and skills needed 
during a crisis, priorities within a crisis readiness plan, and the unique role they play [79].  
The Hospital Emergency Incident Command System more commonly referred to as Hospital Incident 
Command System (HICS) today, was established in the 1980’s to 1990’s by the Emergency Medical 
Services Authority [80]. This structure provides leaders with an approach that can be applied to a 
variety of emergencies as well as settings. Standing up the model may vary depending upon the type 
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of incident, setting, and resources see Figure 6. The structure may evolve over time (days to months) 
depending upon the length of the crisis. 
The incident commander (IC) organizes and directs the command centre and sets the overall 
direction. In regard to COVID-19, there may also be other subject matter experts that provide input 
to the IC including infection prevention, infectious disease, laboratory, and risk management. The 
operations branch is often the largest branch as this considers sub-directors for medical care, 
infrastructure, hazmat, business continuity, and security. There may also be a staging manager that 
assists with employee redeployment, and equipment and medication staging. The planning branch 
focuses on resources (human and material), situational, documentation and demobilization. 
Planning is essential as traditional units may become COVID units and staffing models may need to 
be adjusted due to patient surge. The logistics branch focuses on supplies and support of the HCWs 
and oncology patients. Logistics plays a critical role with oncology HCWs related to PPE and what is 
required to care for a COVID patient versus routine administration of chemotherapy when shortages 
of many products (goggles, masks, gloves, gowns) exists. This branch may also support processes 
related to N95 mask collection for reuse and sterilization. Finally, the finance branch focuses on 
time, procurement, compensation/claims, and cost/expenses see Table 5 Oncology HICS examples. 
Accurate record keeping and decision tracking is critical as the situation unfolds. The IC may 
establish standing meetings, so all section chiefs are aware of key milestones and work plans, this is 








Conclusion   
Globally it is too early to tell what shape that COVID-19 will take and its impact on oncology care.   
 The significance of nurses’ role and contribution is more relevant than ever before; they are the 
cornerstone of health services, either in the frontline offering compassionate care or in leadership 
and education by developing and implementing new policies on standards of care [81].   COVID-19 
poses many challenges for oncology services and people affected by cancer.     However, several 
important clinical considerations have been discussed to inform a way forward in oncology nursing 
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Figure 3. Public Health Core Sciences 
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Figure 5.  Algorithm for staff deployment to labour pools while ensuring core staff in specialty areas 



































Table 1.  Websites and resources during COVID-19 Pandemic 
• National Centre for Infections in Cancer: https://cancerandinfections.org/ 
• American Nurses Association: https://www.nursingworld.org/practice-policy/work-
environment/health-safety/disaster-preparedness/coronavirus/ 
• The Royal College of Nursing: https://www.rcn.org.uk/covid-19 
• Centre for Healthyminds: https://centerhealthyminds.org/well-being-toolkit-covid19 
• Oncology Nursing Society: https://www.ons.org/coronavirus 
• Cancer Nursing Society Australia: https://www.cnsa.org.au/ 
• World Health Organization: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 
• National Comprehensive Cancer Network: https://www.nccn.org/covid-19/default.aspx 


























Table 2. Key Epidemiology Terms (U.S. Centers for Disease Control, 2014) 
  
epidemic or outbreak: disease occurrence among a population that is in excess of what is expected in a given 
time and place. 
cluster: group of cases in a specific time and place that might be more than expected.  
endemic: disease or condition present among a population at all times. 
pandemic: a disease or condition that spreads across regions 










Table 3. Oncology Nursing Society interim recommendations for use of PPE during care delivery and 
administration of hazardous cancer drugs [10] 
PPE ONS Recommendation COVID-19 Interim 
recommendation 
Gowns Disposable poly-coated Regular disposable gown 
(water resistant) 
Cloth gown (facility laundered) 
*  
Masks Mask with face and eye 
protection required only if 
splashing is likely and for 
cleaning of spills 
N95 masks should be reserved 
for symptomatic or COVI-19+ 
patients, hazardous spills and 
clean-up 
Powdered air purifying 
respirators (PAPRs) 
Eye protection Mask with eye protection or 
goggles if splashing is likely 
and for cleaning of spills 
Full facepiece air purifying 
respirators or PAPRs 
Gloves Double chemotherapy-tested 
gloves 
Single chemotherapy tested 
gloves, double standard exam 
gloves, or single standard 
exam glove 
Shoe covers Use in compounding areas 
only 
Work only washable shoes 
Safe handling of Table 1 
NIOSH Drugs 
Poly-coated gown and double 
chemotherapy tested gloves 
(single use to hang or take 
down chemotherapy) 
Use one gown per patient – 
hang gown inside out near 
patient and away from 
surfaces between uses 
One nurse performs all 
takedowns of chemotherapy 
Use gloves only (no gown) for 
lower hazardous risk drugs  










Table 4.  Alternate Care Delivery Model Development: Nursing Considerations 
Nurse scope of practice Accountability 
Delegation 
Supervision 




Workflow Geographic clustering 
Clustering of care 
Staffing projections Intensive Care Unit 
Inpatient care 
Ambulatory care (including infusion and radiation oncology) 
Telehealth 


















Table 5 COVID – 19 Branch Work Examples 
Operations Planning Logistics Finance 
Building of tents for    
drive up testing. 
Employee screening. 
Lock down of doors. 
Swabbing team. 
Unit staging for COVID-




Develops oncology     
staff redeployment    
plan. 
Develops consolidation   
of sites as volumes   
decrease. 
Integration of iPads    
into patient care. 
Telehealth visits for   
survivorship care. 
Inventory of PPE. 
Medical care for health    
care team. 
Purchasing of PPE. 
 
Tracking and coding of    
time devoted to   
response. 
Assists with accounts    
receivable and     
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